Erleada
Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer
Phil Taylor
Astellas, Bayer, Erleada, Johnson & Johnson, Nubeqa, Oncology, Pfizer, Prostate cancer, Xtandi
0 Comment
X
Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer
https://pharmaphorum.com/news/trial-narrows-gap-between-bayers-nubeqa-and-rivals-in-prostate-cancer/
NICE changes its mind on J&J’s Erleada in prostate cancer
Phil Taylor
Erleada, Johnson & Johnson, NHS, NICE, Oncology, Prostate cancer
0 Comment
X
NICE changes its mind on J&J’s Erleada in prostate cancer
https://pharmaphorum.com/news/nice-changes-its-mind-on-jjs-erleada-in-prostate-cancer/
Xtandi catches up with Erleada in castration-sensitive prostate cancer
Phil Taylor
Astellas, Erleada, Oncology, Pfizer, Prostate cancer, Xtandi
0 Comment
X
Xtandi catches up with Erleada in castration-sensitive prostate cancer
https://pharmaphorum.com/news/xtandi-catches-up-with-erleada-in-castration-sensitive-prostate-cancer/